Biologically active substances 'differ in hepatitis E patients'
Hepatitis E patients may have different biologically active substances present in their blood plasma

Bioanalytical

Biologically active substances 'differ in hepatitis E patients'

07 Feb, 2011

Published over 15 years ago. See the latest and most current information on Bioanalytical.

Hepatitis E patients have been studied to determine how the biologically active substances found in their blood plasma differ from healthy individuals.

A team writing in Proteome Science explain how they used mass spectrometry to enrich the peptidome fraction of subjects' plasma.

They were able to identify a number of biologically active substances associated with immune response that were differentially expressed between the infected and control groups.

In turn, they have created a peptide profile they say could be useful in future diagnoses of hepatitis E.

The condition occurs when contaminated drinking water is consumed, according to guidance from the World Health Organization.

However, it is not known to commonly be caused by person-to-person contact, during sex or during blood transfusions.

Moreover, the condition is self-limiting and typically clears up, except in acute cases where fulminant hepatic failure may occur and no known course of treatment exists to alter the outcome.

Latest News

Explore Our Other Sites

Labmate Online
Collaboration supports scalable stem cell therapy manufacturing
Explore more Arrow
Envirotech Online
Uncounted emissions in wastewater expose a gap in monitoring practice
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Digitalisation advances at a large petrochemical complex in China
Explore more Arrow